Product NDC: | 0641-6111 |
Proprietary Name: | Sufentanil Citrate |
Non Proprietary Name: | Sufentanil Citrate |
Active Ingredient(s): | .05 mg/mL & nbsp; Sufentanil Citrate |
Administration Route(s): | EPIDURAL; INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0641-6111 |
Labeler Name: | West-ward Pharmaceutical Corp. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA074413 |
Marketing Category: | ANDA |
Start Marketing Date: | 19951215 |
Package NDC: | 0641-6111-10 |
Package Description: | 10 AMPULE in 1 CARTON (0641-6111-10) > 2 mL in 1 AMPULE (0641-6111-01) |
NDC Code | 0641-6111-10 |
Proprietary Name | Sufentanil Citrate |
Package Description | 10 AMPULE in 1 CARTON (0641-6111-10) > 2 mL in 1 AMPULE (0641-6111-01) |
Product NDC | 0641-6111 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Sufentanil Citrate |
Dosage Form Name | INJECTION |
Route Name | EPIDURAL; INTRAVENOUS |
Start Marketing Date | 19951215 |
Marketing Category Name | ANDA |
Labeler Name | West-ward Pharmaceutical Corp. |
Substance Name | SUFENTANIL CITRATE |
Strength Number | .05 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |